FCG Advisors »

Outlook Therapeutics shares owned by FCG Advisors

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by FCG Advisors from 13F filings

Historical chart of FCG Advisors investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by FCG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by FCG Advisors

Quarter filed Position value Share count Share price at filing
2020-09-30 $11k 16k 0.71

More positions owned by FCG Advisors

Bristol Myers Squibb (BMY)
Ishares Tr S&p 500 Grwt Etf Etf (IVW)
Vanguard Index Fds Extend Mkt Etf Etf (VXF)
Vanguard Tax-managed Ftse Dev Mkt Etf Etf (VEA)
Ishares Tr S&p 500 Val Etf Etf (IVE)
Spdr S&p 500 Etf Tr Tr Unit Etf (SPY)
Apple (AAPL)
Jp Morgan Exchange Traded Fd ultra shrt etf (JMST)
Invesco Exch Trd Slf Bulshs 2022 Cb Etf
Invesco Exch Trd Slf Bulshs 2021 Cb Etf
Johnson & Johnson (JNJ)
Microsoft Corporation (MSFT)
Invesco Exch Trd Slf Bulshs 2023 Cb Etf
Ishares Tr Select Divid Etf Etf (DVY)
Invesco Exch Trd Slf Bulshs 2020 Cb Etf

View all positions for FCG Advisors

Top funds holding Outlook Therapeutics

Vanguard Group
Charles Schwab Investment Management
Rosalind Advisors
Scotia Capital
Millennium Management
Bank of America Corporation
Barclays
Rhumbline Advisers
Gables Capital Management
UBS Group
Ancora Advisors
Jpmorgan Chase & Co
Alliancebernstein
American International
Captrust Financial Advisors

View all funds holding Outlook Therapeutics